Patents Assigned to Diurnal Limited
  • Publication number: 20230066665
    Abstract: We disclose a pharmaceutical composition adapted for oral delivery comprising native testosterone; a treatment regimen comprising administration of the composition(s); and methods and uses for the treatment of hormone related conditions such as hypogonadism in human male, female and transgender subjects.
    Type: Application
    Filed: January 18, 2021
    Publication date: March 2, 2023
    Applicant: Diurnal Limited
    Inventors: Martin Whitaker, John Porter, Richard Ross, Stewart Jones, Elizabeth Cocks
  • Patent number: 10166194
    Abstract: The disclosure relates to a pharmaceutical formulation comprising hydrocortisone and its use in the treatment of conditions that would benefit from a delayed release of hydrocortisone, in particular conditions such as adrenal insufficiency, inflammatory conditions and depression.
    Type: Grant
    Filed: July 5, 2017
    Date of Patent: January 1, 2019
    Assignee: Diurnal Limited
    Inventors: Hiep Huatan, Richard Ross, Martin Whitaker
  • Publication number: 20170296475
    Abstract: The disclosure relates to a pharmaceutical formulation comprising hydrocortisone and its use in the treatment of conditions that would benefit from a delayed release of hydrocortisone, in particular conditions such as adrenal insufficiency, inflammatory conditions and depression.
    Type: Application
    Filed: July 5, 2017
    Publication date: October 19, 2017
    Applicant: Diurnal Limited
    Inventors: Hiep Huatan, Richard Ross, Martin Whitaker
  • Patent number: 9750704
    Abstract: The disclosure relates to a pharmaceutical formulation comprising hydrocortisone and its use in the treatment of conditions that would benefit from a delayed release of hydrocortisone, in particular conditions such as adrenal insufficiency, inflammatory conditions and depression.
    Type: Grant
    Filed: February 12, 2013
    Date of Patent: September 5, 2017
    Assignee: Diurnal Limited
    Inventors: Hiep Huatan, Richard Ross, Martin Whitaker
  • Patent number: 9717740
    Abstract: The disclosure relates to the treatment of adrenal insufficiency with particular but not limiting application to pediatric treatment regimens, the treatment of the elderly and non-human animals.
    Type: Grant
    Filed: March 30, 2017
    Date of Patent: August 1, 2017
    Assignee: Diurnal Limited
    Inventors: Hiep Huatan, Richard Ross, Martin Whitaker
  • Publication number: 20170202856
    Abstract: The disclosure relates to the treatment of adrenal insufficiency with particular but not limiting application to paediatric treatment regimens, the treatment of the elderly and non-human animals.
    Type: Application
    Filed: March 30, 2017
    Publication date: July 20, 2017
    Applicant: Diurnal Limited
    Inventors: Hiep Huatan, Richard Ross, Martin Whitaker
  • Patent number: 9675559
    Abstract: The disclosure relates to the treatment of adrenal insufficiency with particular but not limiting application to pediatric treatment regimens, the treatment of the elderly and non-human animals.
    Type: Grant
    Filed: November 19, 2012
    Date of Patent: June 13, 2017
    Assignee: Diurnal Limited
    Inventors: Hiep Huatan, Richard Ross, Martin Whitaker
  • Patent number: 9649280
    Abstract: The disclosure relates to pharmaceutical compositions useful in the treatment of adrenal insufficiency in paediatric or elderly subjects.
    Type: Grant
    Filed: May 12, 2014
    Date of Patent: May 16, 2017
    Assignee: Diurnal Limited
    Inventors: Hiep Huatan, Richard Ross, Martin Whitaker, Norbert Poellinger, Annette Grave
  • Publication number: 20160081942
    Abstract: The disclosure relates to pharmaceutical compositions useful in the treatment of adrenal insufficiency in paediatric or elderly subjects.
    Type: Application
    Filed: May 12, 2014
    Publication date: March 24, 2016
    Applicant: Diurnal Limited
    Inventors: Hiep Huatan, Richard Ross, Martin Whitaker, Norbert Poellinger, Annette Grave
  • Publication number: 20150133417
    Abstract: We describe lipid based pharmaceutical compositions adapted for oral delivery and optionally delivery in accordance with a circadian rhythm.
    Type: Application
    Filed: January 21, 2015
    Publication date: May 14, 2015
    Applicant: Diurnal Limited
    Inventors: Hiep Huatan, Richard Ross
  • Patent number: 9012436
    Abstract: We describe lipid based pharmaceutical compositions adapted for oral delivery and optionally delivery in accordance with a circadian rhythm.
    Type: Grant
    Filed: April 27, 2009
    Date of Patent: April 21, 2015
    Assignee: Diurnal Limited
    Inventors: Hiep Huatan, Richard Ross
  • Publication number: 20140370113
    Abstract: The disclosure relates to a pharmaceutical formulation comprising hydrocortisone and its use in the treatment of conditions that would benefit from a delayed release of hydrocortisone, in particular conditions such as adrenal insufficiency, inflammatory conditions and depression.
    Type: Application
    Filed: February 12, 2013
    Publication date: December 18, 2014
    Applicant: Diurnal Limited
    Inventors: Hiep Huatan, Richard Ross, Martin Whitaker
  • Publication number: 20140287052
    Abstract: The disclosure relates to the treatment of adrenal insufficiency with particular but not limiting application to paediatric treatment regimens, the treatment of the elderly and non-human animals.
    Type: Application
    Filed: November 19, 2012
    Publication date: September 25, 2014
    Applicant: Diurnal Limited
    Inventors: Hiep Huatan, Richard Ross, Martin Whitaker